Research output

1. Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: Efficacy and safety results of a randomised controlled phase III study

   Research output: Contribution to journal › Article › peer-review

2. Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis

   Research output: Contribution to journal › Article › peer-review

3. Corrigendum to “Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis” (Journal of Neuroimmunology (2019) 337, (S0165572819301687), (10.1016/j.jneuroim.2019.577070))

   Research output: Contribution to journal › Comment/debate › peer-review

View all (77) »